ArticleJournal of molecular medicine (Berlin, Germany)2025

Liensinine can improve vascular remodeling in hypertension through the ferroptosis-related TLR4 inflammatory pathway.

Daxin Chen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.